IDEXX Laboratories (NASDAQ: IDXX) is a veterinary diagnostics company that develops and sells diagnostic products, services, and information management solutions primarily for companion animal veterinary practices. Revenue comes from selling analyzers and instruments placed in clinics, then generating recurring consumable and reagent sales alongside reference laboratory testing services and software subscriptions. The company operates through three reported segments: Companion Animal Group (CAG), which serves veterinarians with diagnostic and information management products; Livestock, Poultry and Dairy (LPD), which provides diagnostic products for livestock and poultry health and milk quality testing; and a third segment referenced in the filing. Customer commitment arrangements, where clinics sign multi-year contracts with minimum annual purchase obligations in exchange for incentives, create recurring revenue and switching costs. IDEXX competes with Ortho-Clinical Diagnostics (a QuidelOrtho subsidiary) in certain diagnostic categories. The company had a $1.25 billion unsecured credit facility as of the 10-K filed February 20, 2026, consisting of a $1 billion revolving facility and a $250 million term loan.

Revenue model

Instrument placement followed by recurring consumable, reagent, and reference lab service revenue. Software and information management subscriptions through the CAG segment. Multi-year customer commitment arrangements provide minimum annual purchase guarantees in exchange for pricing incentives.

Products and services

Companion Animal Group (CAG): in-clinic diagnostic analyzers, IDEXX VetLab Station (IVLS), reference laboratory testing services, information management solutions. Livestock, Poultry and Dairy (LPD): diagnostic products for livestock and poultry health, milk quality and safety testing products.

Customers and end markets

Primary customers are veterinary practices serving companion animals (pets). Secondary end markets include livestock producers, poultry operations, and dairy producers. Clinical visits driving pet-veterinarian interactions are a key demand driver for the CAG segment.

Value-chain role

Manufacturer and service provider of veterinary diagnostic instruments, consumables, and reference laboratory testing. Also provides practice management software and information systems to veterinary clinics.

Geographic exposure

International operations implied by reference to foreign currency exchange rate effects on organic revenue growth, but specific country or regional revenue breakdowns are not supported by the provided filing excerpts.

Competitors

Ortho-Clinical Diagnostics (QuidelOrtho subsidiary)

Source: SEC 10-K, filed 2026-02-20

Industry: In Vitro & In Vivo Diagnostic Substances Peers: Abbott Laboratories ABIOMED INC Baxter International Inc Boston Scientific Corp Edwards Lifesciences Corp Dexcom Inc HOLOGIC INC Insulet Corp Resmed Inc Zimmer Biomet Holdings, Inc